P1530: PERITRANFUSIONAL C1-INHIBITOR IN PATIENTS WITH SEVERE COMPLEMENT-MEDIATED AUTOIMMUNE HEMOLYTIC ANEMIA: AN OPEN LABEL PHASE 2 TRIAL. E. C. W. de Boer, M. Jalink, L. Delvasto-Nuñes, E. M. Meulenbroek, I. Baas, S. R. Janssen, E. E. Dijkman, K. A. Gelderman,D. Wouters, M. D. Engel,M. de Haas,M.-J. Kersten,I. Jongerius,S. Zeerleder,J. M. VosHemaSphere（2022）引用 0|浏览4AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
